Masimo Corp (MASI) 26.59 $MASI
Masimo to Report First Quarter 2014 Financial Results After Market Close on Wednesday, April 30
Marketwire - Thu Apr 17, 7:57AM CDT
Masimo (NASDAQ: MASI) announced today that it will release financial results for the first quarter ended March 29, 2014, after the market closes on Wednesday, April 30, 2014. The conference call to review the results will begin at 1:30 p.m. PT (4:30 p.m. ET) and will be hosted by Joe Kiani, Chairman and Chief Executive Officer, and Mark P. de Raad, Executive Vice President and Chief Financial Officer.
Masimo Reports Encouraging PVI Study Results - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Apr 10, 5:40PM CDT
The results demonstrated that MASI's non-invasive PVI parameter helps clinicians optimize fluid administration for abdominal surgical patients under combined general and epidural anesthesia.
Healthcare Companies Report Recognitions, Schedules, and Stock Movements - Analyst Notes on WellPoint, Quest Diagnostics, LabCorp, Covance, and Masimo
PR Newswire - Tue Apr 08, 7:00AM CDT
Today, Analysts Review released its analysts' notes regarding WellPoint Inc. (NYSE: WLP), Quest Diagnostics Inc. (NYSE: DGX), Laboratory Corp. of America Holdings (NYSE: LH), Covance Inc. (NYSE: CVD), and Masimo Corporation (NASDAQ: MASI). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.AnalystsReview.com/register
New Clinical Study Shows Masimo PVI(R) Helps Clinicians Optimize Fluid Administration in Patients Under Combined General and Epidural Anesthesia
Marketwire - Mon Apr 07, 7:02AM CDT
Masimo (NASDAQ: MASI) announced today a recent study in the Journal of Monitoring and Computing demonstrates that Masimo's noninvasive PVI(R) parameter can help clinicians optimize fluid management and reduce unnecessary fluid administration for abdominal surgical patients under combined general and epidural anesthesia.(1)
Masimo Expands Its Board of Directors With Appointment of Medical Device Executive Craig Reynolds
Marketwire - Fri Apr 04, 4:00AM CDT
Masimo (NASDAQ: MASI), a global innovator of noninvasive patient monitoring technologies, today announced the appointment of seasoned medical device executive Craig B. Reynolds to the Board of Directors of Masimo. Reynolds also will serve as a member of the board's Audit Committee as well as the Compensation Committee.
Global mHealth Market Report 2014: Devices, Applications, Services & Therapeutics 2012 - 2020
M2 - Fri Mar 07, 8:18AM CST
Research and Markets (http://www.researchandmarkets.com/research/994c6r/mhealth_market) has announced the addition of the "Global mHealth Market (Devices, Applications, Services & Therapeutics) 2012 - 2020" report to their offering. The global mHealth market is Expected to Reach $58.8 Billion Globally by 2020 Europe leads the regional market landscape of the global mHealth market followed by Asia Pacific and North America. Furthermore, by 2020, Asia Pacific will take away the lead from North America, occupying more than 28.2% of the market. The players profiled in this report include: Philips healthcare, Omron HealthCare Inc., Bayer Healthcare, LifeWatch, Cardionet Inc., Masimo Corporation, Sanofie, Boston Scientific, AT&T Inc., and Johnson & Johnson. The study observed that the global mHealth market was valued at $6.7 billion in 2012 and is estimated to reach $8.3 billion by the end of 2013. With growing per capita healthcare expenditure both in developed and advanced developing countries. The geography market assessment signifies that Europe along with North America will account for about 55% of the overall market revenue in 2013 and may reduce with growing demand in Asia Pacific region. The study also offers an updated review on the present major market player such as manufacturers of mobile medical devices, and mobile network providers; which also includes description of relevant recent developments activities. Key Topics Covered: Chapter 1 Introduction Chapter 2 Executive Summary Chapter 3 Global Mobile Healthcare (Mhealth) Market Overview Chapter 4 Global Mobile Healthcare (Mhealth) Market - By Devices Chapter 5 Global Mobile Healthcare (Mhealth) Market - By Service Chapter 6 Global Mobile Healthcare (Mhealth) Market - By Stakeholders Chapter 7 Global Mobile Healthcare (Mhealth) Market - By Therapeutic Segment/Specialty Chapter 8 Global Mobile Healthcare (Mhealth) Market - By Geography Chapter 9 Company Profiles For more information visit http://www.researchandmarkets.com/research/99...lth_market
Flagler Hospital Upgrades to Masimo SET(R) Pulse Oximetry for Improved Patient Outcomes
Marketwire - Thu Mar 06, 7:00AM CST
Masimo (NASDAQ: MASI) today announced that Flagler Hospital -- ranked among the top 5% of all hospitals in the nation for both clinical excellence and patient safety for the past eight consecutive years -- has upgraded system-wide to Masimo SET(R) pulse oximetry, the standard-of-care at leading hospitals around the world.
Masimo Down 10.7% Since SmarTrend Downtrend Call (MASI)
Comtex SmarTrend(R) - Tue Mar 04, 9:18AM CST
SmarTrend identified a Downtrend for Masimo (NASDAQ:MASI) on January 31st, 2014 at $28.83. In approximately 1 month, Masimo has returned 10.72% as of today's recent price of $25.74.
Masimo to Present at 26th Annual ROTH Conference
Marketwire - Fri Feb 28, 10:04AM CST
Masimo (NASDAQ: MASI) today announced that its management is scheduled to present at the 26th Annual ROTH Conference at the Ritz-Carlton, Laguna Niguel on Tuesday, March 11, 2014, at 10:00 a.m. Pacific Time. A live audiocast of the presentation will be available on the Masimo website at www.masimo.com. A replay of the audiocast will be available following the live presentation.
North Oaks Medical Center Is First to Integrate Masimo Patient SafetyNet(TM) With EPIC Electronic Medical Record System
Marketwire - Tue Feb 25, 9:14AM CST
Masimo (NASDAQ: MASI) and North Oaks Medical Center -- the 330-bed flagship of North Oaks Health System -- today announced that the facility has gone live with a two-way interface between its EPIC electronic medical record and the Masimo Patient SafetyNet(TM) remote monitoring and clinician notification system.
Concise Analysis of the International Anesthesia and Respiratory Devices Market - Forecast to 2019
M2 - Mon Feb 24, 4:58AM CST
Research and Markets (http://www.researchandmarkets.com/research/zbkqd6/anesthesia_and) has announced the addition of the "Concise Analysis of the International Anesthesia and Respiratory Devices Market - Forecast to 2019" report to their offering. Sophistication and persistent technological advances by respiratory and anesthesia device manufacturers have boosted the growth of this industry. The shift of patient preference from hospital care devices to home healthcare devices has accelerated the growth of this market and encouraged the provision of easy to use and portable devices that have paved a new way to revive this once mature market. According to the new estimates of World Health Organization, COPD is predicted to be become the third leading cause of death by 2030. Approximately 13.6 million adults were diagnosed with COPD in the U.S. alone in year 2012. The rise in geriatric population suffering from COPDs and Asthma are further expected to accelerate the growth of the respiratory devices market. In addition, the annual healthcare expenditures for asthma alone are estimated at $20.7 billion in the U.S. Thus, a rise in pulmonary diseases has helped in growth of this market. Moreover, rise in geriatric population has led to rise in the number of surgeries performed in the country. The American Society of Anestheologists (ASA) estimates 40 million anesthetics being administered each year in the U.S. alone. Thus rise in the number of surgeries coupled with rise in incidence of respiratory diseases have boosted the overall growth of this industry. Key Topics Covered: 1 Preface 2 Executive Summary 3 Global Anesthesia & Respiratory Devices Market Dynamics 4 Anesthesia And Respiratory Devices Market, By Segments 5 Anesthesia And Respiratory Devices Market, By Geography 6 Competitive Landscape 7 Recommendations 8 Company Profiles Companies Mentioned: - Airsep - B Braun Melsungen AG - Carefusion Corporation - Covidien Plc - Draegerwerk AG & Co Kgaa - Getinge Group - Fisher & Paykel Healthcare - GE Healthcare - Philips Healthcare - Resmed - Smiths Medical - Teleflex Incorporated - Masimo Corporation For more information visit http://www.researchandmarkets.com/research/zb...thesia_and
Concise Analysis of the International Blood Pressure Monitoring Testing Market - Forecasts to 2019
M2 - Mon Feb 24, 4:33AM CST
Research and Markets (http://www.researchandmarkets.com/research/mlx76p/blood_pressure) has announced the addition of the "Concise Analysis of the International Blood Pressure Monitoring Testing Market - Forecasts to 2019" report to their offering. The rise in prevalence of high/low blood pressure is attributed to a geriatric population, sedentary lifestyle, lack of physical activity and rising stress. It is estimated that people above the age of 55 years have 90% risk of developing high blood pressure. The global blood pressure monitoring testing market was valued at USD 1,713.3 million in 2012 and is expected to grow at a CAGR of 11.5% from 2013 to 2019, to reach an estimated value of USD 3,661.3 million by 2019. Social, behavioral and metabolic factors determine and contribute to hypertension. Behavioral risk factors such as physical inactivity, unhealthy diet, consumption of alcohol and tobacco, increase the risk of hypertension. Manufacturers are coming up with new and innovative digital blood pressure monitoring devices that are easy to use and provide accurate readings instantly. The digital sphygmomanometers market is expected to grow at a faster rate compared to other types of sphygmomanometers (mercury and aneroid) as they are easy to use and provide accurate results. The trend of regular monitoring is fast catching up, with patients opting for automated self-care, thus making use of personal monitoring devices. Currently, majority of the automated blood pressure monitoring devices available are based on the oscillometric method that gives accurate results, along with ease of use. Key Topics Covered: 1 Preface 2 Executive Summary 3 Market Overview 4 Blood Pressure Monitoring Testing Market, By Segments 5 Blood Pressure Monitoring Testing Market, By Geography 6 Blood Pressure Monitoring Testing Market, By End Users 7 Competitive Landscape 8 Recommendations 9 Company Profiles Companies Mentioned: - A&D Medical, Inc - CONTEC MEDICAL SYSTEMS CO, LTD - Covidien PLC - GE Healthcare - Masimo Corporation - Nihon Kohden Corporation - Omron Healthcare, Inc - Philips Healthcare - Shenzhen Mindray Bio-Medical Electronics Co, Ltd - Spacelabs Healthcare - Suntech Medical, Inc - Welch Allyn For more information visit http://www.researchandmarkets.com/research/ml...d_pressure
Masimo to Present at Raymond James 35th Annual Institutional Investors Conference
Marketwire - Fri Feb 21, 11:18AM CST
Masimo (NASDAQ: MASI) today announced that its management is scheduled to present at the Raymond James 35th Annual Institutional Investors Conference at the JW Marriott Grande Lakes Orlando on Tuesday, March 4, 2014, at 7:30 a.m. Eastern Time. A live audiocast of the presentation will be available on the Masimo website at www.masimo.com. A replay of the audiocast will be available following the live presentation.
Masimo Unveils iSpO2(R) Pulse Oximeter for Android(TM)
Marketwire - Thu Feb 20, 1:30PM CST
Masimo (NASDAQ: MASI) today announced that its award-winning iSpO2(R) pulse oximeter is now available for Android(TM), along with the companion iSpO2 app downloaded from the Google Play(TM) Store. With the release of iSpO2 in the popular Android operating system, more consumers than ever now have access to Masimo SET(R) Measure-through Motion and Low Perfusion(TM) pulse oximetry -- the same technology used in leading hospitals worldwide.
Masimo to Present at 2014 Citi Global Healthcare Conference
Marketwire - Tue Feb 18, 12:48PM CST
Masimo (NASDAQ: MASI) today announced that its management is scheduled to present at the 2014 Citi Global Healthcare Conference at the New York Hilton Midtown on Tuesday, February 25, 2014, at 10:00 a.m. Pacific Time. A live audiocast of the presentation will be available on the Masimo website at www.masimo.com. A replay of the audiocast will be available following the live presentation.
Masimo Q4 Earnings Meet Ests - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Feb 14, 2:43PM CST
For full year 2013, adjusted earnings per share rose 11.5% to $1.16, in line with the Zacks Consensus Estimate.
Quantum Fuel Systems Technologies Worldwide, Inc. Announces Pricing Of 2,050,000 Share Follow-On Offering
PR Newswire - Fri Feb 14, 7:00AM CST
Quantum Fuel Systems Technologies Worldwide, Inc. ("Quantum" or the "Company"
(NASDAQ: QTWW), a leader in the innovation, development and production of natural gas fuel storage systems and the integration of vehicle system technologies including engine and vehicle control systems and drivetrains, today announced it has priced a registered firm commitment underwritten public offering of 2,050,000 shares of its common stock at a price to public of $7.05 per share. Additionally, the Company has granted the underwriter the option to purchase up to an additional 307,500 shares of its common stock to cover over-allotments, if any. The offering is expected to close on or about February 20, 2014, subject to satisfaction of closing conditions.
Masimo Reports Fourth Quarter and Full Year 2013 Financial Results
Marketwire - Thu Feb 13, 3:05PM CST
Masimo (NASDAQ: MASI) today announced its financial results for the fourth quarter and year ended December 28, 2013.
Analyst Alert: Multi-Million Dollar Punitive Damage Award Won by Bonagofsky & Weiss, Dickson Geesman Against Masimo Corporation
Business Wire - Thu Feb 13, 8:00AM CST
Attorneys with Bonagofsky & Weiss and Dickson Geesman today announced one of the largest California arbitration awards of its kind against a global, billiondollar medical technology company.
10 Bills Ready for Debate, Says Lusaka
by John Nalianya - All Africa Global Media - Thu Feb 13, 5:39AM CST
Bungoma Governor Kenneth Lusaka with speaker John Makali and minority leader John Musakali after the official opening of the assembly yesterday.
Masimo to Report First Quarter 2014 Financial Results After Market Close on Wednesday, April 30
Marketwire - Thu Apr 17, 7:57AM CDT
Masimo (NASDAQ: MASI) announced today that it will release financial results for the first quarter ended March 29, 2014, after the market closes on Wednesday, April 30, 2014. The conference call to review the results will begin at 1:30 p.m. PT (4:30 p.m. ET) and will be hosted by Joe Kiani, Chairman and Chief Executive Officer, and Mark P. de Raad, Executive Vice President and Chief Financial Officer.
Masimo Reports Encouraging PVI Study Results - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Apr 10, 5:40PM CDT
The results demonstrated that MASI's non-invasive PVI parameter helps clinicians optimize fluid administration for abdominal surgical patients under combined general and epidural anesthesia.
Healthcare Companies Report Recognitions, Schedules, and Stock Movements - Analyst Notes on WellPoint, Quest Diagnostics, LabCorp, Covance, and Masimo
PR Newswire - Tue Apr 08, 7:00AM CDT
Today, Analysts Review released its analysts' notes regarding WellPoint Inc. (NYSE: WLP), Quest Diagnostics Inc. (NYSE: DGX), Laboratory Corp. of America Holdings (NYSE: LH), Covance Inc. (NYSE: CVD), and Masimo Corporation (NASDAQ: MASI). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.AnalystsReview.com/register
New Clinical Study Shows Masimo PVI(R) Helps Clinicians Optimize Fluid Administration in Patients Under Combined General and Epidural Anesthesia
Marketwire - Mon Apr 07, 7:02AM CDT
Masimo (NASDAQ: MASI) announced today a recent study in the Journal of Monitoring and Computing demonstrates that Masimo's noninvasive PVI(R) parameter can help clinicians optimize fluid management and reduce unnecessary fluid administration for abdominal surgical patients under combined general and epidural anesthesia.(1)
Masimo Expands Its Board of Directors With Appointment of Medical Device Executive Craig Reynolds
Marketwire - Fri Apr 04, 4:00AM CDT
Masimo (NASDAQ: MASI), a global innovator of noninvasive patient monitoring technologies, today announced the appointment of seasoned medical device executive Craig B. Reynolds to the Board of Directors of Masimo. Reynolds also will serve as a member of the board's Audit Committee as well as the Compensation Committee.
Global mHealth Market Report 2014: Devices, Applications, Services & Therapeutics 2012 - 2020
M2 - Fri Mar 07, 8:18AM CST
Research and Markets (http://www.researchandmarkets.com/research/994c6r/mhealth_market) has announced the addition of the "Global mHealth Market (Devices, Applications, Services & Therapeutics) 2012 - 2020" report to their offering. The global mHealth market is Expected to Reach $58.8 Billion Globally by 2020 Europe leads the regional market landscape of the global mHealth market followed by Asia Pacific and North America. Furthermore, by 2020, Asia Pacific will take away the lead from North America, occupying more than 28.2% of the market. The players profiled in this report include: Philips healthcare, Omron HealthCare Inc., Bayer Healthcare, LifeWatch, Cardionet Inc., Masimo Corporation, Sanofie, Boston Scientific, AT&T Inc., and Johnson & Johnson. The study observed that the global mHealth market was valued at $6.7 billion in 2012 and is estimated to reach $8.3 billion by the end of 2013. With growing per capita healthcare expenditure both in developed and advanced developing countries. The geography market assessment signifies that Europe along with North America will account for about 55% of the overall market revenue in 2013 and may reduce with growing demand in Asia Pacific region. The study also offers an updated review on the present major market player such as manufacturers of mobile medical devices, and mobile network providers; which also includes description of relevant recent developments activities. Key Topics Covered: Chapter 1 Introduction Chapter 2 Executive Summary Chapter 3 Global Mobile Healthcare (Mhealth) Market Overview Chapter 4 Global Mobile Healthcare (Mhealth) Market - By Devices Chapter 5 Global Mobile Healthcare (Mhealth) Market - By Service Chapter 6 Global Mobile Healthcare (Mhealth) Market - By Stakeholders Chapter 7 Global Mobile Healthcare (Mhealth) Market - By Therapeutic Segment/Specialty Chapter 8 Global Mobile Healthcare (Mhealth) Market - By Geography Chapter 9 Company Profiles For more information visit http://www.researchandmarkets.com/research/99...lth_market
Flagler Hospital Upgrades to Masimo SET(R) Pulse Oximetry for Improved Patient Outcomes
Marketwire - Thu Mar 06, 7:00AM CST
Masimo (NASDAQ: MASI) today announced that Flagler Hospital -- ranked among the top 5% of all hospitals in the nation for both clinical excellence and patient safety for the past eight consecutive years -- has upgraded system-wide to Masimo SET(R) pulse oximetry, the standard-of-care at leading hospitals around the world.
Masimo Down 10.7% Since SmarTrend Downtrend Call (MASI)
Comtex SmarTrend(R) - Tue Mar 04, 9:18AM CST
SmarTrend identified a Downtrend for Masimo (NASDAQ:MASI) on January 31st, 2014 at $28.83. In approximately 1 month, Masimo has returned 10.72% as of today's recent price of $25.74.
Masimo to Present at 26th Annual ROTH Conference
Marketwire - Fri Feb 28, 10:04AM CST
Masimo (NASDAQ: MASI) today announced that its management is scheduled to present at the 26th Annual ROTH Conference at the Ritz-Carlton, Laguna Niguel on Tuesday, March 11, 2014, at 10:00 a.m. Pacific Time. A live audiocast of the presentation will be available on the Masimo website at www.masimo.com. A replay of the audiocast will be available following the live presentation.
North Oaks Medical Center Is First to Integrate Masimo Patient SafetyNet(TM) With EPIC Electronic Medical Record System
Marketwire - Tue Feb 25, 9:14AM CST
Masimo (NASDAQ: MASI) and North Oaks Medical Center -- the 330-bed flagship of North Oaks Health System -- today announced that the facility has gone live with a two-way interface between its EPIC electronic medical record and the Masimo Patient SafetyNet(TM) remote monitoring and clinician notification system.
Concise Analysis of the International Anesthesia and Respiratory Devices Market - Forecast to 2019
M2 - Mon Feb 24, 4:58AM CST
Research and Markets (http://www.researchandmarkets.com/research/zbkqd6/anesthesia_and) has announced the addition of the "Concise Analysis of the International Anesthesia and Respiratory Devices Market - Forecast to 2019" report to their offering. Sophistication and persistent technological advances by respiratory and anesthesia device manufacturers have boosted the growth of this industry. The shift of patient preference from hospital care devices to home healthcare devices has accelerated the growth of this market and encouraged the provision of easy to use and portable devices that have paved a new way to revive this once mature market. According to the new estimates of World Health Organization, COPD is predicted to be become the third leading cause of death by 2030. Approximately 13.6 million adults were diagnosed with COPD in the U.S. alone in year 2012. The rise in geriatric population suffering from COPDs and Asthma are further expected to accelerate the growth of the respiratory devices market. In addition, the annual healthcare expenditures for asthma alone are estimated at $20.7 billion in the U.S. Thus, a rise in pulmonary diseases has helped in growth of this market. Moreover, rise in geriatric population has led to rise in the number of surgeries performed in the country. The American Society of Anestheologists (ASA) estimates 40 million anesthetics being administered each year in the U.S. alone. Thus rise in the number of surgeries coupled with rise in incidence of respiratory diseases have boosted the overall growth of this industry. Key Topics Covered: 1 Preface 2 Executive Summary 3 Global Anesthesia & Respiratory Devices Market Dynamics 4 Anesthesia And Respiratory Devices Market, By Segments 5 Anesthesia And Respiratory Devices Market, By Geography 6 Competitive Landscape 7 Recommendations 8 Company Profiles Companies Mentioned: - Airsep - B Braun Melsungen AG - Carefusion Corporation - Covidien Plc - Draegerwerk AG & Co Kgaa - Getinge Group - Fisher & Paykel Healthcare - GE Healthcare - Philips Healthcare - Resmed - Smiths Medical - Teleflex Incorporated - Masimo Corporation For more information visit http://www.researchandmarkets.com/research/zb...thesia_and
Concise Analysis of the International Blood Pressure Monitoring Testing Market - Forecasts to 2019
M2 - Mon Feb 24, 4:33AM CST
Research and Markets (http://www.researchandmarkets.com/research/mlx76p/blood_pressure) has announced the addition of the "Concise Analysis of the International Blood Pressure Monitoring Testing Market - Forecasts to 2019" report to their offering. The rise in prevalence of high/low blood pressure is attributed to a geriatric population, sedentary lifestyle, lack of physical activity and rising stress. It is estimated that people above the age of 55 years have 90% risk of developing high blood pressure. The global blood pressure monitoring testing market was valued at USD 1,713.3 million in 2012 and is expected to grow at a CAGR of 11.5% from 2013 to 2019, to reach an estimated value of USD 3,661.3 million by 2019. Social, behavioral and metabolic factors determine and contribute to hypertension. Behavioral risk factors such as physical inactivity, unhealthy diet, consumption of alcohol and tobacco, increase the risk of hypertension. Manufacturers are coming up with new and innovative digital blood pressure monitoring devices that are easy to use and provide accurate readings instantly. The digital sphygmomanometers market is expected to grow at a faster rate compared to other types of sphygmomanometers (mercury and aneroid) as they are easy to use and provide accurate results. The trend of regular monitoring is fast catching up, with patients opting for automated self-care, thus making use of personal monitoring devices. Currently, majority of the automated blood pressure monitoring devices available are based on the oscillometric method that gives accurate results, along with ease of use. Key Topics Covered: 1 Preface 2 Executive Summary 3 Market Overview 4 Blood Pressure Monitoring Testing Market, By Segments 5 Blood Pressure Monitoring Testing Market, By Geography 6 Blood Pressure Monitoring Testing Market, By End Users 7 Competitive Landscape 8 Recommendations 9 Company Profiles Companies Mentioned: - A&D Medical, Inc - CONTEC MEDICAL SYSTEMS CO, LTD - Covidien PLC - GE Healthcare - Masimo Corporation - Nihon Kohden Corporation - Omron Healthcare, Inc - Philips Healthcare - Shenzhen Mindray Bio-Medical Electronics Co, Ltd - Spacelabs Healthcare - Suntech Medical, Inc - Welch Allyn For more information visit http://www.researchandmarkets.com/research/ml...d_pressure
Masimo to Present at Raymond James 35th Annual Institutional Investors Conference
Marketwire - Fri Feb 21, 11:18AM CST
Masimo (NASDAQ: MASI) today announced that its management is scheduled to present at the Raymond James 35th Annual Institutional Investors Conference at the JW Marriott Grande Lakes Orlando on Tuesday, March 4, 2014, at 7:30 a.m. Eastern Time. A live audiocast of the presentation will be available on the Masimo website at www.masimo.com. A replay of the audiocast will be available following the live presentation.
Masimo Unveils iSpO2(R) Pulse Oximeter for Android(TM)
Marketwire - Thu Feb 20, 1:30PM CST
Masimo (NASDAQ: MASI) today announced that its award-winning iSpO2(R) pulse oximeter is now available for Android(TM), along with the companion iSpO2 app downloaded from the Google Play(TM) Store. With the release of iSpO2 in the popular Android operating system, more consumers than ever now have access to Masimo SET(R) Measure-through Motion and Low Perfusion(TM) pulse oximetry -- the same technology used in leading hospitals worldwide.
Masimo to Present at 2014 Citi Global Healthcare Conference
Marketwire - Tue Feb 18, 12:48PM CST
Masimo (NASDAQ: MASI) today announced that its management is scheduled to present at the 2014 Citi Global Healthcare Conference at the New York Hilton Midtown on Tuesday, February 25, 2014, at 10:00 a.m. Pacific Time. A live audiocast of the presentation will be available on the Masimo website at www.masimo.com. A replay of the audiocast will be available following the live presentation.
Masimo Q4 Earnings Meet Ests - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Feb 14, 2:43PM CST
For full year 2013, adjusted earnings per share rose 11.5% to $1.16, in line with the Zacks Consensus Estimate.
Quantum Fuel Systems Technologies Worldwide, Inc. Announces Pricing Of 2,050,000 Share Follow-On Offering
PR Newswire - Fri Feb 14, 7:00AM CST
Quantum Fuel Systems Technologies Worldwide, Inc. ("Quantum" or the "Company"
(NASDAQ: QTWW), a leader in the innovation, development and production of natural gas fuel storage systems and the integration of vehicle system technologies including engine and vehicle control systems and drivetrains, today announced it has priced a registered firm commitment underwritten public offering of 2,050,000 shares of its common stock at a price to public of $7.05 per share. Additionally, the Company has granted the underwriter the option to purchase up to an additional 307,500 shares of its common stock to cover over-allotments, if any. The offering is expected to close on or about February 20, 2014, subject to satisfaction of closing conditions. Masimo Reports Fourth Quarter and Full Year 2013 Financial Results
Marketwire - Thu Feb 13, 3:05PM CST
Masimo (NASDAQ: MASI) today announced its financial results for the fourth quarter and year ended December 28, 2013.
Analyst Alert: Multi-Million Dollar Punitive Damage Award Won by Bonagofsky & Weiss, Dickson Geesman Against Masimo Corporation
Business Wire - Thu Feb 13, 8:00AM CST
Attorneys with Bonagofsky & Weiss and Dickson Geesman today announced one of the largest California arbitration awards of its kind against a global, billiondollar medical technology company.
10 Bills Ready for Debate, Says Lusaka
by John Nalianya - All Africa Global Media - Thu Feb 13, 5:39AM CST
Bungoma Governor Kenneth Lusaka with speaker John Makali and minority leader John Musakali after the official opening of the assembly yesterday.
